Hubei Jumpcan Pharmaceutical Statistics

Total Valuation

Hubei Jumpcan Pharmaceutical has a market cap or net worth of CNY 29.20 billion. The enterprise value is 18.75 billion.

Market Cap	29.20B
Enterprise Value	18.75B

Important Dates

The last earnings date was Wednesday, October 23, 2024.

Earnings Date	Oct 23, 2024
Ex-Dividend Date	Jun 17, 2024

Share Statistics

Hubei Jumpcan Pharmaceutical has 921.70 million shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class	n/a
Shares Outstanding	921.70M
Shares Change (YoY)	-0.20%
Shares Change (QoQ)	-1.03%
Owned by Insiders (%)	5.22%
Owned by Institutions (%)	12.11%
Float	340.65M

Valuation Ratios

The trailing PE ratio is 10.46 and the forward PE ratio is 9.58.

PE Ratio	10.46
Forward PE	9.58
PS Ratio	3.26
PB Ratio	2.06
P/TBV Ratio	n/a
P/FCF Ratio	13.67
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.23, with an EV/FCF ratio of 8.78.

EV / Earnings	6.74
EV / Sales	2.10
EV / EBITDA	6.23
EV / EBIT	6.90
EV / FCF	8.78

Financial Position

The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.09.

Current Ratio	3.72
Quick Ratio	3.54
Debt / Equity	0.09
Debt / EBITDA	0.41
Debt / FCF	0.57
Interest Coverage	89.59

Financial Efficiency

Return on equity (ROE) is 20.97% and return on invested capital (ROIC) is 11.86%.

Return on Equity (ROE)	20.97%
Return on Assets (ROA)	9.78%
Return on Capital (ROIC)	11.86%
Revenue Per Employee	1.71M
Profits Per Employee	531,827
Employee Count	5,230
Asset Turnover	0.51
Inventory Turnover	2.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.32% in the last 52 weeks. The beta is 0.15, so Hubei Jumpcan Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+17.32%
50-Day Moving Average	28.79
200-Day Moving Average	33.93
Relative Strength Index (RSI)	59.96
Average Volume (20 Days)	8,954,832

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hubei Jumpcan Pharmaceutical had revenue of CNY 8.92 billion and earned 2.78 billion in profits. Earnings per share was 3.03.

Revenue	8.92B
Gross Profit	7.13B
Operating Income	2.72B
Pretax Income	3.27B
Net Income	2.78B
EBITDA	3.01B
EBIT	2.72B
Earnings Per Share (EPS)	3.03

Full Income Statement

Balance Sheet

The company has 11.70 billion in cash and 1.23 billion in debt, giving a net cash position of 10.47 billion or 11.36 per share.

Cash & Cash Equivalents	11.70B
Total Debt	1.23B
Net Cash	10.47B
Net Cash Per Share	11.36
Equity (Book Value)	14.10B
Book Value Per Share	15.37
Working Capital	10.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.34 billion and capital expenditures -207.70 million, giving a free cash flow of 2.14 billion.

Operating Cash Flow	2.34B
Capital Expenditures	-207.70M
Free Cash Flow	2.14B
FCF Per Share	2.32

Full Cash Flow Statement

Margins

Gross margin is 79.92%, with operating and profit margins of 30.47% and 31.17%.

Gross Margin	79.92%
Operating Margin	30.47%
Pretax Margin	36.66%
Profit Margin	31.17%
EBITDA Margin	33.70%
EBIT Margin	30.47%
FCF Margin	23.94%

Dividends & Yields

This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 4.08%.

Dividend Per Share	1.30
Dividend Yield	4.08%
Dividend Growth (YoY)	47.73%
Years of Dividend Growth	2
Payout Ratio	43.91%
Buyback Yield	0.20%
Shareholder Yield	4.28%
Earnings Yield	9.56%
FCF Yield	7.32%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hubei Jumpcan Pharmaceutical has an Altman Z-Score of 6.93.

Altman Z-Score	6.93
Piotroski F-Score	n/a